Add to ORKGHow to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA websit
The use of opiates at high doses in cancer pain can cause the appearance of side effects such as con...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(55) / BLDSC - British Librar...
Abstract Introduction Intrathecal drug delivery (ITDD) systems are an option for the management of ...
The first implanted fixed rate pumps were used in humans in the mid-1980s [1]. In 1991, Medtronic ® ...
Management of chronic pain by intrathecal delivery is gaining increasing use. The aim of this articl...
This search strategy sought to construct an evidence-based position on the use of intrathecal pumps....
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/93560/1/j.1526-4637.2012.01456.x.pd
Most patients suffering from neuropathic pain will not obtain sufficient pain relief from current re...
The objective of our study was to describe an effective technique for the management of chronic intr...
The prevalence of chronic pain is between 33% to 64% and is due to cancer pain, but it has also been...
Continuous Intrathecal Drug Delivery through an implanted pump is a well-known therapeutic option fo...
Jeremy A Adler,1 Neona M Lotz2 1Pacific Pain Medicine Consultants, Encinitas, 2Cypress Ambulatory Su...
In this thesis, we tried to study and determine the impact and long-term action methodologies intrat...
Evidence-based medicine depends on the existence of controlled clinical trials that establish the sa...
Intrathecal drug delivery appeared in the early eighties and allows to administer high concentrate a...
The use of opiates at high doses in cancer pain can cause the appearance of side effects such as con...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(55) / BLDSC - British Librar...
Abstract Introduction Intrathecal drug delivery (ITDD) systems are an option for the management of ...
The first implanted fixed rate pumps were used in humans in the mid-1980s [1]. In 1991, Medtronic ® ...
Management of chronic pain by intrathecal delivery is gaining increasing use. The aim of this articl...
This search strategy sought to construct an evidence-based position on the use of intrathecal pumps....
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/93560/1/j.1526-4637.2012.01456.x.pd
Most patients suffering from neuropathic pain will not obtain sufficient pain relief from current re...
The objective of our study was to describe an effective technique for the management of chronic intr...
The prevalence of chronic pain is between 33% to 64% and is due to cancer pain, but it has also been...
Continuous Intrathecal Drug Delivery through an implanted pump is a well-known therapeutic option fo...
Jeremy A Adler,1 Neona M Lotz2 1Pacific Pain Medicine Consultants, Encinitas, 2Cypress Ambulatory Su...
In this thesis, we tried to study and determine the impact and long-term action methodologies intrat...
Evidence-based medicine depends on the existence of controlled clinical trials that establish the sa...
Intrathecal drug delivery appeared in the early eighties and allows to administer high concentrate a...
The use of opiates at high doses in cancer pain can cause the appearance of side effects such as con...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(55) / BLDSC - British Librar...
Abstract Introduction Intrathecal drug delivery (ITDD) systems are an option for the management of ...